Smiths Medical allegedly conspired with United Therapeutics to stifle a generic version of pulmonary arterial hypertension drug Remodulin, according to a lawsuit filed this week by Novartis (NYSE:NVS) unit Sandoz. The Smiths Group (LON:SMIN) subsidiary, which is slated for a spinout as a separately traded company next year, makes the infusion pumps and single-use cartridges for […]
Report: Smiths may abandon talks of merger with ICU Medical
Smiths Group (LON:SMIN) may walk away from talks of a $9 billion merger of its healthcare division with ICU Medical (NSDQ:ICUI), Sky News reported this week. The two groups began talks more than two months ago, but Smiths is reportedly leaning towards a decision to abandon negotiations. Talks of a potential merger have sparked interest by Baxter to pursue […]
Smiths Medical debuts drug pump software
Smiths Group (LON:SMIN) Smiths Medical division today launched an updated version of its PharmGuard interoperability software for its Medfusion 4000 wireless syringe pumps. The new version features bi-directional integration with any IHE compatible electronic medical record system, the company said. Smart pump programming allows a clinician order to be sent directly to the Medfusion pump, […]
